SMTL ID : 3tfq.2 (1 other biounit)

Crystal structure of 11b-hsd1 double mutant (l262r, f278e) complexed with 8-{[(2-CYANOPYRIDIN-3-YL)METHYL]SULFANYL}-6-HYDROXY-3,4-DIHYDRO-1H-PYRANO[3,4-C]PYRIDINE-5-CARBONITRILE

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

homo-dimer

Ligands

2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 29 residues within 4Å: Chain A: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, E.88, N.113, H.114, I.115, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: 07M.2 33 PLIP interactions: 33 interactions with chain A Hydrophobic interactions: A:L.209, A:I.212 Hydrogen bonds: A:G.35, A:S.37, A:S.37, A:K.38, A:I.40, A:R.60, A:S.61, A:T.86, A:T.86, A:M.87, A:E.88, A:N.113, A:I.115, A:Y.141, A:K.181, A:I.212, A:T.214, A:T.214, A:T.214, A:T.216, A:T.216 Water bridges: A:S.37, A:K.38, A:G.39, A:G.41, A:R.60, A:R.60, A:R.60, A:N.113 Salt bridges: A:K.38, A:R.60 NAP.3: 31 residues within 4Å: Chain B: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, E.88, N.113, H.114, I.115, N.117, Y.141, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: 07M.4 30 PLIP interactions: 30 interactions with chain B Hydrophobic interactions: B:L.209 Hydrogen bonds: B:G.35, B:S.37, B:S.37, B:K.38, B:I.40, B:R.60, B:S.61, B:T.86, B:T.86, B:M.87, B:N.113, B:I.115, B:Y.141, B:K.181, B:I.212, B:T.214, B:T.214, B:T.216, B:T.216 Water bridges: B:K.38, B:G.39, B:G.41, B:R.60, B:R.60, B:N.113, B:T.116, B:N.117 Salt bridges: B:K.38, B:R.60

2 x 07M: 8-{[(2-cyanopyridin-3-yl)methyl]sulfanyl}-6-hydroxy-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile(Non-covalent)

07M.2: 19 residues within 4Å: Chain A: I.115, T.118, S.119, L.120, S.164, L.165, Y.171, V.174, Y.177, L.209, G.210, L.211, T.216, A.217, A.220, V.221, V.225, M.227 Ligands: NAP.1 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:I.115, A:Y.171, A:Y.177 Hydrogen bonds: A:S.164, A:L.165, A:A.166, A:Y.177 07M.4: 18 residues within 4Å: Chain B: I.115, T.118, S.119, L.120, S.164, L.165, Y.171, V.174, Y.177, L.209, G.210, L.211, T.216, A.217, A.220, V.225, M.227 Ligands: NAP.3 8 PLIP interactions: 8 interactions with chain B Hydrophobic interactions: B:I.115, B:Y.171, B:Y.177 Hydrogen bonds: B:S.164, B:L.165, B:A.166, B:Y.177 Water bridges: B:Y.171

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.5: 4 residues within 4Å: Chain B: N.201, V.202, S.203, R.246 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:R.246

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wu, S.C. et al., Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11beta-hydroxydehydrogenase 1 (11beta-HSD1). Bioorg.Med.Chem.Lett. (2011)

Release Date

2011-11-02

Peptides

Corticosteroid 11-beta-dehydrogenase isozyme 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
E

Corticosteroid 11-beta-dehydrogenase isozyme 1

Related Entries With Identical Sequence